Navigation Links
UC San Diego bioengineering professor trey ideker wins 2009 Overton Prize
Date:3/13/2009

dent when, in 2001, he published a classic paper [in the journal Science] demonstrating how biological networks are mapped and tested using a systems biology approach that has attracted well over 800 citations to date. He then took a fellowship at the prestigious Whitehead Institute for Biomedical Research in Cambridge, Massachusetts before joining the faculty at UC San Diego in 2003, where he is now an associate professor.

In recent years, Ideker has developed a number of influential bioinformatics methods and resources including Cytoscape, a widely used open source program for visualizing molecular networks. In 2003, his group was the first to demonstrate that protein networks can be aligned and compared across species, just like genome sequences. Since then, he has extended network comparison to incorporate many different interaction types, and used network-based methods to map the DNA damage response, compare host and pathogen networks, and classify diseases.

Ideker has already received many honors and was recognized as one of the top 10 innovators of 2006 by MIT's Technology Review.

Aviv Regev, the 2008 ISCB Overton Prize winner, commends the selection of Ideker for the 2009 award. "Trey's work has epitomized the power of integrating innovative computational methods with cutting-edge genomics. His pioneering work has set a model for doing systems biology that has been followed by numerous groups and has impacts for understanding the evolution of biological systems and for treating disease."


'/>"/>

Contact: Daniel Kane
dbkane@ucsd.edu
858-534-3262
University of California - San Diego
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. UC San Diego physicists tackle knotty puzzle
2. UC-San Diego Engineering Honor Society wins most outstanding chapter award
3. Experimental Biology 2008 meets in San Diego April 5-9
4. UC San Diego begins trading greenhouse gas credits on Chicago Climate Exchange
5. San Diego Harbor Police Deploy BIO-key(R) Automated Vehicle Location System
6. Biologists at UC San Diego identify key protein in cells self-eating function
7. UC San Diego researchers eliminate drug discovery bottleneck
8. Glowing films developed by UC San Diego chemists reveal traces of explosives
9. UC San Diego researchers identify potential new drug candidates to combat bird flu
10. UC San Diego launches Institute of Engineering in Medicine to accelerate health care tech
11. UC San Diego researchers could help US military thwart explosive threats
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UC San Diego bioengineering professor trey ideker wins 2009 Overton Prize
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used ... measures the overall facial feature of a person ... distance between eyes. Facial recognition is used for ...
(Date:12/11/2014)... SALEM, N.C. , Dec. 10, 2014  That blood ... for quite a while. Hypertension – the medical term for ... in the early 1800s, and the inflatable cuff that,s used ... That doesn,t, however, mean there,s nothing new about hypertension, its ... some long-held beliefs about the condition and the best ways ...
(Date:12/10/2014)... 9, 2014  Valencell, a leader in performance biometric ... staggering demand from its licensees for highly accurate, clinically ... not solely coming from fitness and health sectors, but ... "A wearable is only as useful as the biometric ... ultimate driver in long-term mass consumer adoption of wearable ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... additional brush strokes to the revolutionary new image now emerging ... cord. Their report, which suggests a key role for astrocytes ... online in ACS, Journal of Proteome Research , a ... point out that nearly everyone viewed astrocytes the most ...
... from The University of Alabama used worms to reel in ... of cellular mechanisms that may be exploited to treat epilepsy. ... ( http://www.genetics.org ), the researchers explain how the transparent ... switches" that control the transport of a molecule (gamma-aminobutyric acid ...
... taint" smell in the meat and allows them to contain ... different. Now, for the first time, a scientific team has ... The main conclusion of the study, that forms part of ... by the livestock farmers, without anaesthetic and in some cases, ...
Cached Biology News:More than fish bait: Worms unlock secrets to new epilepsy treatments 277 percent of European pigs are castrated without anesthetic 2
(Date:12/24/2014)... ST. LOUIS , Dec. 23, 2014 /PRNewswire/ ... announced today that the waiting period under the ... with the acquisition expired on December 22, 2014, ... and review requirement for the acquisition of the ... U.S. antitrust clearance satisfies another condition to ...
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ - RepliCel Life ... regenerative medicine company focused on the development of autologous ... out of the University of Calgary in conjunction with ... Carolina, which further validates the company,s ongoing clinical research ... effects of pattern baldness. The paper entitled ...
(Date:12/22/2014)... December 22, 2014 ITRA Global, one ... occupiers of commercial real estate, has further expanded its ... in Perth and Brisbane, Western Australia, reports Mylinda Vick, ... , ITRA Global / ACORPP (Australian Corporate Property ... consultancy company providing property services to a wide range ...
(Date:12/19/2014)... 2014 Naurex Inc., a biopharmaceutical company leveraging ... of the central nervous system, today announced that ... will present at the 33 rd annual J.P. ... at 3:00 p.m. PST on Tuesday, January 13, 2015, ... Francisco, Calif. About Naurex ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
... today announced,that researchers will present eight abstracts ... Meeting of the American Thoracic Society, from ... Presentations are designed to showcase,MedImmune,s biologics capabilities., ... solutions that may one,day help patients struggling ...
... Novasys Medical, Inc., a,developer of innovative therapies ... $49.5 million in Series D preferred stock financing. ... Partners and Skyline,Ventures also participating as new investors. ... Capital Management, Alloy,Ventures, Delphi Ventures, GBS Venture Partners, ...
... Revenues Increase Over 29% From Previous Quarter, ... (OTC:,SPOM), a leading developer of biosensor and microprocessor ... first quarter results for,the period ended March 31, ... US$1,079,000, a 29% increase over,fourth quarter 2007 gross ...
Cached Biology Technology:Depth of MedImmune's Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society 2Novasys Medical Secures $49.5 Million in Series D Financing to Expand Commercialization of Its Renessa(R) Treatment for Incontinence in Women 2SPO Medical Reports First Quarter 2008 Results 2SPO Medical Reports First Quarter 2008 Results 3
Tight junctions are complexes of proteins that create intercellular boundaries between the plasma membrane domains of epithelial and endothelial cells. Antigen: Synthetic peptide corresponding to...
Polyclonal Antibody to TRIB1/ SKIP1/ Tribbles 1...
TNF-Related Apoptosis Inducing Ligand-Receptor-1...
PMA (YPMA-1)...
Biology Products: